FDG-PET May Predict Response to Neoadjuvant Therapy in Pancreatic Cancer

THURSDAY, Sept. 15, 2022 -- For patients with borderline resectable/locally advanced (BR/LA) pancreatic ductal adenocarcinoma (PDAC), preoperative fluorodeoxyglucose positron emission tomography (FDG-PET) may predict pathologic response to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news